Advertisement
BLZE vs DBD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLZE is a Hold and DBD is a StrongBuy.
BLZE in -23.12% downward trend, falling for three consecutive days on October 14, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BLZE declined for three days, in 249 of 301 cases, the price declined further within the following month. The odds of a continued downward trend are 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BLZE as a result. In 71 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for BLZE turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLZE advanced for three days, in 228 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BLZE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 153 of 178 cases where BLZE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.020) is normal, around the industry mean (15.867). P/E Ratio (-24.600) is within average values for comparable stocks, (56.069). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.212) among similar stocks. P/S Ratio (4.936) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. BLZE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLZE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
DBD in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for DBD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on DBD as a result. In 43 of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for DBD just turned positive on October 01, 2026. Looking at past instances where DBD's MACD turned positive, the stock continued to rise in 23 of 32 cases over the following month. The odds of a continued upward trend are 72%.
DBD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in 174 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
DBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for DBD entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. DBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.387) is normal, around the industry mean (-1.734). P/E Ratio (22.275) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.074) among similar stocks. P/S Ratio (0.606) is also within normal values, averaging (71.128).
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
| BLZE | DBD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 86% | 1 day ago 77% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 81% |
| MACD ODDS (%) | 1 day ago 82% | 1 day ago 72% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 80% |
| Advances ODDS (%) | 21 days ago 80% | 1 day ago 79% |
| Declines ODDS (%) | 9 days ago 83% | 15 days ago 60% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 79% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BLZE’s FA Score shows that 2 FA rating(s) are green while DBD’s FA Score has 0 green FA rating(s).
- BLZE’s FA Score: 2 green, 3 red.
- DBD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BLZE’s TA Score shows that 5 TA indicator(s) are bullish while DBD’s TA Score has 6 bullish TA indicator(s).
- BLZE’s TA Score: 5 bullish, 3 bearish.
- DBD’s TA Score: 6 bullish, 3 bearish.
Price Growth
BLZE (@Computer Communications) experienced а -3.96% price change this week, while DBD (@Packaged Software) price change was +4.04% for the same time period.
The average weekly price growth across all stocks in the @Computer Communications industry was -1.36%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +4.51%.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.42%. For the same industry, the average monthly price growth was -3.95%, and the average quarterly price growth was +4.32%.
Reported Earning Dates
BLZE is expected to report earnings on Nov 02, 2026.
DBD is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Computer Communications (-1.36% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
@Packaged Software (-0.42% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
BLZE and
Correlation & Price change
A.I.dvisor indicates that over the last year, BLZE has been loosely correlated with RIOT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BLZE jumps, then RIOT could also see price increases.
| Ticker / NAME | Correlation To BLZE | 1D Price Change % | ||
|---|---|---|---|---|
| BLZE | 100% | -7.82% | ||
| RIOT - BLZE | 53% Loosely correlated | -8.06% | ||
| SPT - BLZE | 53% Loosely correlated | +3.23% | ||
| COIN - BLZE | 51% Loosely correlated | -4.51% | ||
| CLSK - BLZE | 49% Loosely correlated | -6.86% | ||
| AMPL - BLZE | 47% Loosely correlated | +3.33% | ||
More | ||||
DBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.
| Ticker / NAME | Correlation To DBD | 1D Price Change % | ||
|---|---|---|---|---|
| DBD | 100% | +1.61% | ||
| GDRX - DBD | 49% Loosely correlated | +1.40% | ||
| RAMP - DBD | 47% Loosely correlated | +0.10% | ||
| BLZE - DBD | 43% Loosely correlated | -7.82% | ||
| EEFT - DBD | 42% Loosely correlated | +1.73% | ||
| PAYO - DBD | 41% Loosely correlated | +0.14% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DEUS | 67.25 | 0.69 | +1.04% |
| Xtrackers Russell US Multifactor ETF (DEUS) | |||
| TMYY | 19.98 | -0.14 | -0.67% |
| GraniteShares YieldBOOST TSM ETF (TMYY) | |||
| PTNQ | 84.93 | -2.58 | -2.95% |
| Pacer Trendpilot 100 ETF (PTNQ) | |||
| FAZ | 33.30 | -1.10 | -3.20% |
| Direxion Daily Financial Bear 3X ETF (FAZ) | |||
| AAOG | 0.85 | -0.26 | -23.74% |
| Leverage Shares 2X Long AAOI Daily ETF (AAOG) | |||